The generic injectable market in China is witnessing a significant expansion, with a projected compound annual growth rate (CAGR) of 7.8%. The market is expected to surge from USD 12.5 million in 2025 to USD 26.7 million by 2035. This remarkable growth is being driven by the rising burden of chronic diseases, advancements in pharmaceutical …